247 related articles for article (PubMed ID: 26738368)
21. The relationship between inflammatory markers and disability in chronic obstructive pulmonary disease (COPD).
Garrod R; Marshall J; Barley E; Fredericks S; Hagan G
Prim Care Respir J; 2007 Aug; 16(4):236-40. PubMed ID: 17665081
[TBL] [Abstract][Full Text] [Related]
22. [Correlation between serum marker variations and pulmonary hypertension secondary to chronic obstructive pulmonary disease].
Xie X; Wang X; Zhang Y; Han D; Li S; Li M
Nan Fang Yi Ke Da Xue Xue Bao; 2013 Oct; 33(10):1458-62. PubMed ID: 24144746
[TBL] [Abstract][Full Text] [Related]
23. Dynamic pulmonary hyperinflation and low grade systemic inflammation in stable COPD patients.
Gatta D; Aliprandi G; Pini L; Zanardini A; Fredi M; Tantucci C
Eur Rev Med Pharmacol Sci; 2011 Sep; 15(9):1068-73. PubMed ID: 22013730
[TBL] [Abstract][Full Text] [Related]
24. Daily step count is associated with plasma C-reactive protein and IL-6 in a US cohort with COPD.
Moy ML; Teylan M; Weston NA; Gagnon DR; Danilack VA; Garshick E
Chest; 2014 Mar; 145(3):542-550. PubMed ID: 24091482
[TBL] [Abstract][Full Text] [Related]
25. High sensitive C-reactive protein for prediction of adverse outcome in acute exacerbation of chronic obstructive pulmonary disease.
Tofan F; Rahimi-Rad MH; Rasmi Y; Rahimirad S
Pneumologia; 2012; 61(3):160-2. PubMed ID: 23175870
[TBL] [Abstract][Full Text] [Related]
26. Relationship between serum cardiac troponin T level and cardiopulmonary function in stable chronic obstructive pulmonary disease.
Hattori K; Ishii T; Motegi T; Kusunoki Y; Gemma A; Kida K
Int J Chron Obstruct Pulmon Dis; 2015; 10():309-20. PubMed ID: 25709425
[TBL] [Abstract][Full Text] [Related]
27. [Characteristics of stable chronic obstructive pulmonary disease related to systemic inflammation].
Solanes I; Bolíbar I; Llauger MA; Medrano C; Peiró M; Fraga M; Pou MA; Giner J; Freixas M; Plaza V;
Med Clin (Barc); 2012 Oct; 139(10):430-6. PubMed ID: 22766062
[TBL] [Abstract][Full Text] [Related]
28. [Correlation among the levels of C-reactive protein and interleukin-18, quality of life, and lung function in patients with chronic obstructive pulmonary disease].
Long H; Luo H; Chen P; Li Y
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2011 Nov; 36(11):1090-6. PubMed ID: 22169727
[TBL] [Abstract][Full Text] [Related]
29. Impaired systemic vascular reactivity & raised high-sensitivity C reactive protein levels in chronic obstructive pulmonary disease.
Khare P; Talwar A; Chandran D; Guleria R; Jaryal AK; Kumar G; Trivedi A; Deepak KK
Indian J Med Res; 2016 Feb; 143(2):205-12. PubMed ID: 27121518
[TBL] [Abstract][Full Text] [Related]
30. Highly sensitive C-reactive protein levels in Iranian patients with pulmonary complication of sulfur mustard poisoning and its correlation with severity of airway diseases.
Attaran D; Lari SM; Khajehdaluee M; Ayatollahi H; Towhidi M; Asnaashari A; Marallu HG; Mazloomi M; Mood MB
Hum Exp Toxicol; 2009 Dec; 28(12):739-45. PubMed ID: 19919970
[TBL] [Abstract][Full Text] [Related]
31. Association between Ω3 and Ω6 fatty acid intakes and serum inflammatory markers in COPD.
de Batlle J; Sauleda J; Balcells E; Gómez FP; Méndez M; Rodriguez E; Barreiro E; Ferrer JJ; Romieu I; Gea J; Antó JM; Garcia-Aymerich J;
J Nutr Biochem; 2012 Jul; 23(7):817-21. PubMed ID: 21889886
[TBL] [Abstract][Full Text] [Related]
32. Biomarkers of systemic inflammation in stable and exacerbation phases of COPD.
Karadag F; Karul AB; Cildag O; Yilmaz M; Ozcan H
Lung; 2008; 186(6):403-9. PubMed ID: 18807087
[TBL] [Abstract][Full Text] [Related]
33. Circulating vascular endothelial growth factor and systemic inflammatory markers in patients with stable and exacerbated chronic obstructive pulmonary disease.
Valipour A; Schreder M; Wolzt M; Saliba S; Kapiotis S; Eickhoff P; Burghuber OC
Clin Sci (Lond); 2008 Oct; 115(7):225-32. PubMed ID: 18307413
[TBL] [Abstract][Full Text] [Related]
34. Rosuvastatin treatment in stable chronic obstructive pulmonary disease (RODEO): a randomized controlled trial.
Neukamm A; Høiseth AD; Einvik G; Lehmann S; Hagve TA; Søyseth V; Omland T
J Intern Med; 2015 Jul; 278(1):59-67. PubMed ID: 25495178
[TBL] [Abstract][Full Text] [Related]
35. Prevalence of anaemia associated with chronic obstructive pulmonary disease. Study of associated variables.
Comeche Casanova L; Echave-Sustaeta JM; García Luján R; Albarrán Lozano I; Alonso González P; Llorente Alonso MJ
Arch Bronconeumol; 2013 Sep; 49(9):383-7. PubMed ID: 23791383
[TBL] [Abstract][Full Text] [Related]
36. Variation in high-sensitivity C-reactive protein levels over 24 hours in patients with stable coronary artery disease.
Koc M; Karaarslan O; Abali G; Batur MK
Tex Heart Inst J; 2010; 37(1):42-8. PubMed ID: 20200626
[TBL] [Abstract][Full Text] [Related]
37. Determinants of systemic vascular function in patients with stable chronic obstructive pulmonary disease.
Eickhoff P; Valipour A; Kiss D; Schreder M; Cekici L; Geyer K; Kohansal R; Burghuber OC
Am J Respir Crit Care Med; 2008 Dec; 178(12):1211-8. PubMed ID: 18836149
[TBL] [Abstract][Full Text] [Related]
38. Gender difference in plasma fatty-acid-binding protein 4 levels in patients with chronic obstructive pulmonary disease.
Zhang X; Li D; Wang H; Pang C; Wu Y; Wen F
Biosci Rep; 2016 Jan; 36(1):e00302. PubMed ID: 26823558
[TBL] [Abstract][Full Text] [Related]
39. Associations of Trauma Severity with Mean Platelet Volume and Levels of Systemic Inflammatory Markers (IL1β, IL6, TNFα, and CRP).
Alper B; Erdogan B; Erdogan MÖ; Bozan K; Can M
Mediators Inflamm; 2016; 2016():9894716. PubMed ID: 27127347
[TBL] [Abstract][Full Text] [Related]
40. Inflammatory markers according to types of atrial fibrillation.
Gedikli O; Dogan A; Altuntas I; Altinbas A; Ozaydin M; Akturk O; Acar G
Int J Cardiol; 2007 Aug; 120(2):193-7. PubMed ID: 17240468
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
